Welcome to the MSRC Website

Sep 06, 2010 10:36PM

Malpractice liability costs U.S. $55.6 billion: study

WASHINGTON (Reuters) - Medical malpractice liability costs the U.S. healthcare system more than $55 billion a year, most of it in "defensive" medical practices such as extra tests and scans, according to a report released on Tuesday.

Sep 07, 2010 04:25AM

Long-term weight loss may be harmful to health

HONG KONG (Reuters) - Long-term weight loss may release into the blood industrial pollutants linked to illnesses like diabetes, hypertension and rheumatoid arthritis, researchers said on Tuesday.

Sep 07, 2010 05:09AM

Magic mushrooms may ease anxiety of cancer: study

CHICAGO (Reuters) - The hallucinogen psilocybin -- known by the street name magic mushrooms -- may help ease the anxiety that often accompanies late-stage cancer, U.S. researchers said on Monday.

Sep 05, 2010 04:10PM

UK wants GSK's Avandia pulled as EU reviews safety

LONDON (Reuters) - GlaxoSmithKline's diabetes drug Avandia should be pulled from sale because of concerns about heart risks, British drug regulators said on Monday ahead of a special European meeting on the drug's safety.

Sep 06, 2010 01:11PM

Mental illness alone not linked to violence

LONDON (Reuters) - Mental illnesses like schizophrenia or bipolar disorder alone do not make people more violent, but the tendency of people with psychiatric problems to abuse drugs or alcohol does, scientists said on Monday.

Sep 06, 2010 01:10PM

Study links cholesterol and nonstick coating chemical

CHICAGO (Reuters) - Chemicals used to make non-stick coatings on cookware and to waterproof fabrics may raise levels of cholesterol in children, U.S. researchers said on Monday.

Sep 05, 2010 06:48AM

Bangladesh issues red alert over spread of anthrax

DHAKA (Reuters) - Bangladesh issued a red alert on Sunday over an outbreak of anthrax which has infected nearly 300 people and killed about 150 cattle in the north of the country in the past two weeks.

Sep 05, 2010 09:41AM

Sanofi ready to raise bid if Genzyme talks: report

PARIS (Reuters) - French drugmaker Sanofi-Aventis would be prepared to moderately raise its $69 per share offer for Genzyme if the U.S. biotech agreed to negotiate, Dow Jones reported, citing a person familiar with the matter.

Sep 03, 2010 10:18AM

Special Report: Outgunned FDA tries to get tough with drug ads

SILVER SPRING, Maryland (Reuters) - It wasn't what you would call a casual get-together.

Sep 03, 2010 06:39PM

Early day care may promote eczema development

NEW YORK (Reuters Health) - Kids who spend their earliest years in day care may be at higher risk of eczema than kids cared for at home, according to a new study from Germany.